Treatment of moderately to severely active systemic lupus erythematosus with adrenocorticotropic hormone: a single-site, open-label trial

BACKGROUND: Alternative therapeutic options are needed for patients with systemic lupus erythematosus (SLE) not adequately controlled with or intolerant to traditional treatments. This study evaluated the efficacy of Acthar® Gel (ACTH((1-39))) for reducing active SLE severity among patients receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiechtner, JJ, Montroy, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232266/
https://www.ncbi.nlm.nih.gov/pubmed/24795067
http://dx.doi.org/10.1177/0961203314532562

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232266/
https://www.ncbi.nlm.nih.gov/pubmed/24795067
http://dx.doi.org/10.1177/0961203314532562

Ejemplares similares